Integrating CardioOncology Across the Research Pipeline, Policy, and Practice in Australia—An Australian Cardiovascular Alliance Perspective
Anna C. Singleton,Julie Redfern,Abbey Diaz,Bogda Koczwara,Stephen J. Nicholls,Kazuaki Negishi,Andre La Gerche,David Playford,Rachel Conyers,Daniel A. Cehic,Gail Garvey,Trent D. Williams,Lee Hunt,Kerry Doyle,Gemma A. Figtree,Doan T.M. Ngo,Aaron L. Sverdlov,Australian Cardiovascular Alliance Cardio-Oncology Working Group,Mary Kavurma,Alex Pinto,Grant Drummond,Rebecca Ritchie,Peter Barlis,Peter Meikle,Alicia Jenkins,Chris Reid,Vincent Thijs,Lee Nedkoff,Dominique Cadilhac,Garry Jennings AO,Julie Redfern
DOI: https://doi.org/10.1016/j.hlc.2024.01.011
2024-02-01
Abstract:Over 18 million people worldwide were diagnosed with cancer in 2020, including over 150,000 people in Australia. Although improved early detection and treatment have increased the survival rates, cardiotoxic treatment and inadequate management of cardiovascular risk factors have resulted in cardiovascular disease (CVD) being one of the leading causes of non-cancer-related death and disability among cancer survivors. International guidelines outline the standards of care for CVD risk surveillance and management. However, Australian cardio-oncology policies and clinical guidelines are limited. There is increasing growth of cardio-oncology research in Australia and support from leading Australian professional bodies and advocacy and research networks, including the Cardiac Society of Australia and New Zealand, the Clinical Oncology Society of Australia, the National Heart Foundation of Australia, and the Australian Cardiovascular Alliance (ACvA). Thus, opportunities to drive multidisciplinary cardio-oncology initiatives are growing, including grant funding, position statements, and novel research to inform new policies. The ACvA has a unique flagship structure that spans the translational research pipeline from drug discovery to implementation science. This article aims to highlight how multidisciplinary cardio-oncology innovations could intersect with the seven ACvA flagships, and to showcase Australian achievements in cardio-oncology thus far. We summarise eight key priority areas for future cardio-oncology research that emerged. These strategies will strengthen cardio-oncology research and care in Australia, and drive new guidelines, policies, and government initiatives to ensure equity in health outcomes for all cardio-oncology patients.
cardiac & cardiovascular systems